Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Collier

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
ACR Open Rheumatology|June 25, 2023
Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Jacqueline O'Brien, Nicole Middaugh, et al.
Arthritis Research & Therapy|September 9, 2021
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registryPhilip J Mease, Scott Stryker, Mei Liu, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
RMD Open|January 29, 2016
Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registryPhilip J Mease, David H Collier, Katherine C Saunders, et al.
The Journal of Rheumatology|April 3, 2019
Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona RegistryDimitrios A Pappas, Sabrina Rebello, Mei Liu, et al.
Clinical and Experimental Rheumatology|November 19, 2013
Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experienceGrant W Cannon, Brian C Wang, Grace S Park, et al.
The Journal of Rheumatology|April 15, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid ArthritisJeffrey R Curtis, Paul Emery, Greg Kricorian, et al.
The Journal of Rheumatology|January 17, 2017
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical RegistryPhilip J Mease, Tamara Lesperance, Mei Liu, et al.
Journal of Managed Care & Specialty Pharmacy|December 12, 2019
Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on EtanerceptMachaon Bonafede, Hafiz Oko-Osi, Mahdi Gharaibeh, et al.
Arthritis Research & Therapy|October 23, 2020
Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritisBrian C Sauer, Wei Chen, Yizhe Xu, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
ACR Open Rheumatology|June 25, 2023
Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Jacqueline O'Brien, Nicole Middaugh, et al.
Arthritis Research & Therapy|September 9, 2021
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registryPhilip J Mease, Scott Stryker, Mei Liu, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
RMD Open|January 29, 2016
Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registryPhilip J Mease, David H Collier, Katherine C Saunders, et al.
The Journal of Rheumatology|April 3, 2019
Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona RegistryDimitrios A Pappas, Sabrina Rebello, Mei Liu, et al.
Clinical and Experimental Rheumatology|November 19, 2013
Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experienceGrant W Cannon, Brian C Wang, Grace S Park, et al.
The Journal of Rheumatology|April 15, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid ArthritisJeffrey R Curtis, Paul Emery, Greg Kricorian, et al.
The Journal of Rheumatology|January 17, 2017
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical RegistryPhilip J Mease, Tamara Lesperance, Mei Liu, et al.
Journal of Managed Care & Specialty Pharmacy|December 12, 2019
Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on EtanerceptMachaon Bonafede, Hafiz Oko-Osi, Mahdi Gharaibeh, et al.
Arthritis Research & Therapy|October 23, 2020
Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritisBrian C Sauer, Wei Chen, Yizhe Xu, et al.
Pageof 5